{"id":6250,"date":"2025-01-28T11:55:07","date_gmt":"2025-01-28T10:55:07","guid":{"rendered":"https:\/\/ww2.omceoge.it\/?page_id=6250"},"modified":"2025-01-28T11:55:07","modified_gmt":"2025-01-28T10:55:07","slug":"6250-alisa-prot-n-1834-del-27-01-2025-trasmissione-comunicazioni-aifa-cessata-commercializzazione-epsodilave-250-ui-5-ml-aic-034630018-9","status":"publish","type":"post","link":"https:\/\/www.omceoge.it\/home9\/item\/6250-alisa-prot-n-1834-del-27-01-2025-trasmissione-comunicazioni-aifa-cessata-commercializzazione-epsodilave-250-ui-5-ml-aic-034630018-9\/","title":{"rendered":"<img src=\"https:\/\/ww2.omceoge.it\/home9\/wp-content\/uploads\/alisa.png\" class=\"custom-title-icon\" style=\" vertical-align:middle; display:inline-block;\">ALISA &#8211; Prot. n. 1834 &#8211; del 27\/01\/2025 &#8211;  Trasmissione comunicazioni AIFA &#8211; Cessata commercializzazione Epsodilave 250 UI\/5 ml (AIC 034630018 9"},"content":{"rendered":"<p>Pubblichiamo la comunicazione di ALisa prot. 1834 rigardante Cessata commercializzazione Epsodilave 250 UI\/5 ml (AIC 034630018 9<\/p>\n<hr class=\"readMore\">\n<div class=\"allegati_pdf\">\n<div class=\"div_pdf_js\"><a data-post-title=\"&lt;img src=&quot;https:\/\/ww2.omceoge.it\/home9\/wp-content\/uploads\/alisa.png&quot; class=&quot;custom-title-icon&quot; style=&quot; vertical-align:middle; display:inline-block;&quot;&gt;ALISA &#8211; Prot. n. 1834 &#8211; del 27\/01\/2025 &#8211;  Trasmissione comunicazioni AIFA &#8211; Cessata commercializzazione Epsodilave 250 UI\/5 ml (AIC 034630018 9\" data-context=\"list\" class=\"a_pdf_file\" href=\"\/home8\/media\/k2\/attachments\/PDFsam_merge_137.pdf\"><img data-post-title=\"&lt;img src=&quot;https:\/\/ww2.omceoge.it\/home9\/wp-content\/uploads\/alisa.png&quot; class=&quot;custom-title-icon&quot; style=&quot; vertical-align:middle; display:inline-block;&quot;&gt;ALISA &#8211; Prot. n. 1834 &#8211; del 27\/01\/2025 &#8211;  Trasmissione comunicazioni AIFA &#8211; Cessata commercializzazione Epsodilave 250 UI\/5 ml (AIC 034630018 9\" data-context=\"list\" decoding=\"async\" class=\"img_pdf_js\" src=\"\/home9\/wp-content\/uploads\/pdf-png.png\"><span class=\"span_pdf_title\">Alisa 1834<\/span><\/a><span class=\"span_pdf_url\"><\/span><\/div>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>Pubblichiamo la comunicazione di ALisa prot. 1834 rigardante Cessata commercializzazione Epsodilave 250 UI\/5 ml (AIC 034630018 9<\/p>\n","protected":false},"author":563,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[46],"tags":[],"class_list":["post-6250","post","type-post","status-publish","format-standard","hentry","category-notizie-dall-aifa"],"acf":[],"_links":{"self":[{"href":"https:\/\/www.omceoge.it\/home9\/wp-json\/wp\/v2\/posts\/6250","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.omceoge.it\/home9\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.omceoge.it\/home9\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.omceoge.it\/home9\/wp-json\/wp\/v2\/users\/563"}],"replies":[{"embeddable":true,"href":"https:\/\/www.omceoge.it\/home9\/wp-json\/wp\/v2\/comments?post=6250"}],"version-history":[{"count":0,"href":"https:\/\/www.omceoge.it\/home9\/wp-json\/wp\/v2\/posts\/6250\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.omceoge.it\/home9\/wp-json\/wp\/v2\/media?parent=6250"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.omceoge.it\/home9\/wp-json\/wp\/v2\/categories?post=6250"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.omceoge.it\/home9\/wp-json\/wp\/v2\/tags?post=6250"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}